RedHill Biopharma (RDHL) Competitors $1.83 -0.02 (-1.08%) As of 05/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDHL vs. PRPH, ME, IBIO, FLGC, SYBX, MRKR, NXTC, AYTU, CLDI, and BCTXShould you be buying RedHill Biopharma stock or one of its competitors? The main competitors of RedHill Biopharma include ProPhase Labs (PRPH), 23andMe (ME), iBio (IBIO), Flora Growth (FLGC), Synlogic (SYBX), Marker Therapeutics (MRKR), NextCure (NXTC), Aytu BioPharma (AYTU), Calidi Biotherapeutics (CLDI), and BriaCell Therapeutics (BCTX). These companies are all part of the "pharmaceutical products" industry. RedHill Biopharma vs. ProPhase Labs 23andMe iBio Flora Growth Synlogic Marker Therapeutics NextCure Aytu BioPharma Calidi Biotherapeutics BriaCell Therapeutics ProPhase Labs (NASDAQ:PRPH) and RedHill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability. Does the MarketBeat Community favor PRPH or RDHL? RedHill Biopharma received 313 more outperform votes than ProPhase Labs when rated by MarketBeat users. Likewise, 65.69% of users gave RedHill Biopharma an outperform vote while only 48.93% of users gave ProPhase Labs an outperform vote. CompanyUnderperformOutperformProPhase LabsOutperform Votes11448.93% Underperform Votes11951.07% RedHill BiopharmaOutperform Votes42765.69% Underperform Votes22334.31% Do insiders and institutionals believe in PRPH or RDHL? 9.4% of ProPhase Labs shares are owned by institutional investors. Comparatively, 7.2% of RedHill Biopharma shares are owned by institutional investors. 20.7% of ProPhase Labs shares are owned by company insiders. Comparatively, 6.8% of RedHill Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is PRPH or RDHL more profitable? RedHill Biopharma has a net margin of 0.00% compared to ProPhase Labs' net margin of -217.64%. RedHill Biopharma's return on equity of 0.00% beat ProPhase Labs' return on equity.Company Net Margins Return on Equity Return on Assets ProPhase Labs-217.64% -62.92% -30.22% RedHill Biopharma N/A N/A N/A Which has more risk and volatility, PRPH or RDHL? ProPhase Labs has a beta of -0.47, indicating that its stock price is 147% less volatile than the S&P 500. Comparatively, RedHill Biopharma has a beta of 4.33, indicating that its stock price is 333% more volatile than the S&P 500. Does the media prefer PRPH or RDHL? In the previous week, ProPhase Labs had 8 more articles in the media than RedHill Biopharma. MarketBeat recorded 9 mentions for ProPhase Labs and 1 mentions for RedHill Biopharma. ProPhase Labs' average media sentiment score of 0.37 beat RedHill Biopharma's score of 0.00 indicating that ProPhase Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ProPhase Labs 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RedHill Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, PRPH or RDHL? RedHill Biopharma has higher revenue and earnings than ProPhase Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProPhase Labs$6.77M1.98-$16.78M-$1.26-0.25RedHill Biopharma$8.04M0.40$23.92MN/AN/A SummaryRedHill Biopharma beats ProPhase Labs on 8 of the 13 factors compared between the two stocks. Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDHL vs. The Competition Export to ExcelMetricRedHill BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.26M$6.46B$5.33B$8.31BDividend YieldN/A2.63%5.27%4.09%P/E RatioN/A8.3626.7119.58Price / Sales0.40258.94395.60135.07Price / Cash0.0165.8538.3234.62Price / Book0.056.416.764.50Net Income$23.92M$143.73M$3.23B$248.40M7 Day Performance-0.54%0.31%0.36%-0.85%1 Month Performance-20.69%0.14%7.03%8.09%1 Year Performance-99.36%0.31%18.59%8.75% RedHill Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDHLRedHill Biopharma0.1902 of 5 stars$1.84-0.5%N/A-99.4%$3.26M$8.04M0.00210Gap DownPRPHProPhase Labs1.8296 of 5 stars$0.32-17.2%N/A-94.0%$13.43M$6.77M-0.25130Earnings ReportGap DownME23andMeN/A$0.50-35.3%N/A-95.1%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeIBIOiBio1.1623 of 5 stars$0.800.0%$4.30+438.0%-63.1%$13.20M$375,000.000.00100Gap DownFLGCFlora Growth2.4836 of 5 stars$0.67-1.6%$4.00+501.5%-41.5%$12.93M$59.51M-0.68280SYBXSynlogicN/A$1.10+1.9%N/A-28.5%$12.87M$8,000.00-0.2680Upcoming EarningsMRKRMarker Therapeutics4.2164 of 5 stars$1.13+1.8%$13.17+1,065.2%-72.0%$12.79M$6.59M-0.8560NXTCNextCure3.9359 of 5 stars$0.45+2.7%$3.50+677.8%-68.5%$12.62MN/A-0.2290Gap UpAYTUAytu BioPharma1.4503 of 5 stars$2.00-6.1%N/A-38.8%$12.34M$77.23M-1.38160High Trading VolumeCLDICalidi Biotherapeutics1.7644 of 5 stars$0.42+2.0%$10.00+2,292.3%N/A$11.90M$50,000.000.0038Gap DownBCTXBriaCell Therapeutics1.2775 of 5 stars$3.20+8.8%$32.00+900.0%-85.7%$11.87MN/A-0.248Gap Down Related Companies and Tools Related Companies ProPhase Labs Competitors 23andMe Competitors iBio Competitors Flora Growth Competitors Synlogic Competitors Marker Therapeutics Competitors NextCure Competitors Aytu BioPharma Competitors Calidi Biotherapeutics Competitors BriaCell Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDHL) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RDHL Stock Free RDHL Stock Alerts